| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |